Abbott Laboratories will distribute supplies of certain nutritional formulas designed for people with rare metabolic diseases made at a Michigan manufacturing plant that is the subject of an investigation by the Food and Drug Administration into possible bacterial contamination.

Abbott said Friday it is releasing the formula for free to patients on a case-by-case basis at the request of the FDA to ease shortages.

To Read the Full Story

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Chinese city officials issue a rare apology after authorities harass journalists on live TV

TAIPEI, Taiwan — City officials in eastern China apologized to local journalists after authorities…

Noise Complaint: The Gym Downstairs Is Very Loud

Q: I recently purchased an apartment in a condominium in New York…

Protesters arrested after demanding justice for deadly subway chokehold

IE 11 is not supported. For an optimal experience visit our site…

Tesla is now sitting on $2.5 billion of bitcoin

Tesla is sitting on roughly $2.5 billion worth of bitcoin, according to…